What Does Health Insurance Consolidation Mean for You?
Listen to this Marketplace report on consolidation in the world of health insurance. It is an interesting report, and also the first public acknowledgment that I am, gulp, a Business Professor!
Listen to this Marketplace report on consolidation in the world of health insurance. It is an interesting report, and also the first public acknowledgment that I am, gulp, a Business Professor!
In a recent Atlantic post, James Hamblin reports on the increasing frequency with which surgeons perform hysterectomies with the assistance of robots. Here is a picture from that post: To be clear: robotic surgery doesn’t mean a robot performs the operation. Instead, the surgeon uses a laparoscope, usually, and the surgeon controls the tools at…
During his campaign, President Trump promised to “end inflation and make America affordable again, to bring down the prices of all goods.” In honor of that promise, Dr. Mehmet Oz, head of the Medicare program, should address the enormous increase in what Medicare patients are being asked to pay for drugs. Medicare drug coverage is…
I teach an undergraduate health policy class at Duke, populated in part by ambitious premeds. (Sorry for that last bit of redundancy.) One of the things I like to emphasize in the class is the kind of medical practice milieu students can expect to encounter when they finally become physicians. That’s a good way to…
Shutterstock If you get health insurance through your job, beware: you might be picking up more of the cost of your medical care than you realize. With increasing frequency, employers are directing their workers to the kind of high deductible, high out-of-pocket insurance plans that leave workers financially responsible for a surprising portion of their…
I am not a fan of judging the quality of a nation’s healthcare system by examining life expectancy. Many, many factors influence life expectancy that have nothing to do with healthcare. When examining life expectancy in developed countries, for example, all of which have decent healthcare systems, your best bets at predicting differences across countries…
In exciting news for breast cancer patients, the FDA recently approved Perjeta, a new treatment for metastatic breast cancer that delays progression of the disease by six months. But can we afford to offer this drug to every woman who could potentially benefit?… (Read more and view comments at Forbes)